368PClinicopathological characteristics, survival and prognostic factors of breast cancer-related microangiopathic haemolytic anemia: A multicenter study

ConclusionsThis study is the first attempt at characterizing BC-MAHA, which appears to be more frequent in the lobular subtype. In spite of a dismal median OS, a few patients experienced long-term survival and we document, for the first-time, prognostic factors that may guide therapeutic decision making.Legal entity responsible for the studyFran çois-Clément Bidard (Institut Curie, Paris, France).FundingHas not received any funding.DisclosureF.C. Bidard: Speaker Bureau / Expert testimony, Research grant / Funding (institution), Travel / Accommodation / Expenses: Pfizer; Advisory / Consultancy: AstraZeneca; Advisory / Consultancy, Research grant / Funding (institution): Novartis; Advisory / Consultancy: Lilly; Research grant / Funding (institution), Travel / Accommodation / Expenses: Roche; Research grant / Funding (institution), Travel / Accommodation / Expenses: Menarini Silicon Biosystems; Speaker Bureau / Expert testimony: Amgen. P. Heudel: Honoraria (self), Travel / Accommodation / Expenses: Novartis; Honoraria (self), Travel / Accommodation / Expenses: Pfizer; Travel / Accommodation / Expenses: Sandoz; Travel / Accommodation / Expenses: Roche. J. Pierga: Honoraria (institution), Research grant / Funding (self): Amgen; Honoraria (self), Research grant / Funding (self): AstraZeneca; Honoraria (self), Research grant / Funding (self), Research grant / Funding (institution): Roche; Honoraria (self), Research grant / Funding (self): illumina; Honoraria (self), Research grant...
Source: Annals of Oncology - Category: Cancer & Oncology Source Type: research